Dilzem 180 mg RR
Dilzem 180 mg RR is a medicine authorised by Swissmedic under authorisation number 49577. The authorisation holder is Pfizer AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 29 December 1987 and the authorisation is valid without a time limit. ATC code C08DB01 places the medicine in the group Calcium channel blockers.
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Dilzem 180 mg RR, Retardtabletten | B | 29 December 1987 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 28 | 30 | Tablette(n) | C08DB01 | 02.06.1. | B |
| 36 | 100 | Tablette(n) | C08DB01 | 02.06.1. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Dilzem 180 mg RR authorised in Switzerland?
Yes. Dilzem 180 mg RR is authorised by Swissmedic under authorisation number 49577, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Dilzem 180 mg RR have?
Dilzem 180 mg RR is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Dilzem 180 mg RR?
The authorisation holder is Pfizer AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.